Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 181
Filtrer
3.
AJNR Am J Neuroradiol ; 41(4): 639-644, 2020 04.
Article de Anglais | MEDLINE | ID: mdl-32165366

RÉSUMÉ

BACKGROUND AND PURPOSE: The increased severity of white matter disease is associated with worse outcomes and an increased rate of intracerebral hemorrhage in patients with ischemic stroke undergoing thrombolytic treatment. However, whether white matter disease is associated with outcomes in patients undergoing endovascular treatment remains unclear. MATERIALS AND METHODS: In this prespecified exploratory analysis of our prospective multi-institutional study that enrolled consecutive adult patients with anterior circulation ischemic stroke undergoing endovascular treatment from November 2017 to September 2018, we compared the following outcomes between patients with none-to-minimal (van Swieten score, 0-2) and moderate-to-severe (van Swieten score, 3-4) white matter disease using logistic regression: 90-day mRS 3-6, death, intracerebral hemorrhage, successful recanalization, and early neurologic recovery. RESULTS: Of the 485 patients enrolled in the Blood Pressure after Endovascular Stroke Therapy (BEST) study, 389 had white matter disease graded (50% women; median age, 68 years; range, 58-79 years). A van Swieten score of 3-4 (n = 74/389, 19%) was associated with a higher rate of 90-day mRS of 3-6 (45% versus 18%; adjusted OR, 2.73; 95% CI, 1.34-5.93; P = .008). Although the death rate was higher in patients with van Swieten scores of 3-4 (26% versus 15%), the adjusted likelihood was not significantly different (adjusted OR, 1.14; 95% CI, 0.56-2.26; P = .710). Ordered regression revealed a shift toward worse mRS scores with increasing van Swieten scores (adjusted common OR, 3.04; 95% CI, 1.93-4.84; P < .001). No associations between white matter disease severity and intracerebral hemorrhage, successful recanalization, and early neurologic recovery were observed. CONCLUSIONS: Moderate-to-severe white matter disease is associated with worse outcomes in patients undergoing endovascular treatment without a significant increase in hemorrhagic complications. Studies comparing patients with and without endovascular treatment are necessary to determine whether the benefit of endovascular treatment is attenuated with greater white matter disease.


Sujet(s)
Leucoencéphalopathies/complications , Accident vasculaire cérébral/complications , Accident vasculaire cérébral/chirurgie , Thrombectomie/méthodes , Résultat thérapeutique , Sujet âgé , Encéphalopathie ischémique/complications , Procédures endovasculaires/méthodes , Femelle , Humains , Mâle , Adulte d'âge moyen , Études prospectives
4.
J Prev Med Hyg ; 60(4): E300-E310, 2019 Dec.
Article de Anglais | MEDLINE | ID: mdl-31967087

RÉSUMÉ

OBJECTIVES: The aim was to provide an affordable method of computing socio-economic (SE) deprivation indices at the regional level, in order to reveal the specific aspects of the relationship between SE inequalities and health outcomes. The Umbria Region Socio-Health Index (USHI) was computed and compared with the Italian National Deprivation Index at the Umbria regional level (NDI-U). METHODS: The USHI was computed by applying factor analysis to census tract SE variables correlated with general mortality and validated through comparison with the NDI-U. RESULTS: Overall mortality presented linear positive trends in USHI, while trends in NDI-U proved non-linear or non-significant. Similar results were obtained with regard to specific causes of death according to deprivation groups, gender and age. CONCLUSIONS: The USHI better describes a local population in terms of health-related SE status. Policy-makers could therefore adopt this method in order to obtain a better picture of SE-associated health conditions in regional populations and to target strategies for reducing health inequalities.


Sujet(s)
Disparités de l'état de santé , Mortalité , Santé publique , Caractéristiques de l'habitat , Classe sociale , Facteurs socioéconomiques , Adolescent , Adulte , Sujet âgé , Cause de décès , Enfant , Enfant d'âge préscolaire , Femelle , Ressources en santé , Humains , Nourrisson , Nouveau-né , Italie , Mâle , Adulte d'âge moyen , Jeune adulte
7.
Nutr Metab Cardiovasc Dis ; 27(11): 956-963, 2017 Nov.
Article de Anglais | MEDLINE | ID: mdl-28967595

RÉSUMÉ

BACKGROUND AND AIMS: Metabolic factors initiating adipose tissue expansion and ectopic triglyceride accumulation are not completely understood. We aimed to investigate the independent role of circulating glucose, NEFA and insulin on glucose and NEFA uptake, and lipogenesis in skeletal muscle and subcutaneous adipose tissue (SCAT). METHODS AND RESULTS: Twenty-two pigs were stratified according to four protocols: 1) and 2) low NEFA + high insulin ± high glucose (hyperinsulinaemia-hyperglycaemia or hyperinsulinaemia-euglycaemia), 3) high NEFA + low insulin (fasting), 4) low NEFA + low insulin (nicotinic acid). Positron emission tomography with [18F]fluoro-2-deoxyglucose and [11C]acetate, was combined with [14C]acetate and [U-13C]palmitate enrichment techniques to assess glucose and lipid metabolism. Hyperinsulinaemia increased glucose extraction, whilst hyperglycaemia enhanced glucose uptake in skeletal muscle and SCAT. In SCAT, during hyperglycaemia, elevated glucose uptake was accompanied by greater [U-13C]palmitate-TG enrichment compared to the other groups, and by a 39% increase in de novo lipogenesis (DNL) compared to baseline, consistent with a 70% increment in plasma lipogenic index. Conversely, in skeletal muscle, [U-13C]palmitate-TG enrichment was higher after prolonged fasting. CONCLUSIONS: Our data show the necessary role of hyperglycaemia-hyperinsulinaemia vs euglycaemia-hyperinsulinaemia in promoting expansion of TG stores in SCAT, by the consensual elevation in plasma NEFA and glucose uptake and DNL. In contrast, skeletal muscle NEFA uptake for TG synthesis is primarily driven by circulating NEFA levels. These results suggest that a) prolonged fasting or dietary regimens enhancing lipolysis might promote muscle steatosis, and b) the control of glucose levels, in association with adequate energy balance, might contribute to weight loss.


Sujet(s)
Glycémie/métabolisme , Acide gras libre/sang , Insuline/sang , Lipogenèse , Muscles squelettiques/métabolisme , Graisse sous-cutanée/métabolisme , Triglycéride/biosynthèse , Animaux , Biopsie , Modèles animaux de maladie humaine , Acide gras libre/administration et posologie , Hyperglycémie/sang , Hyperinsulinisme/sang , Insuline/administration et posologie , Lipogenèse/effets des médicaments et des substances chimiques , Mâle , Muscles squelettiques/imagerie diagnostique , Muscles squelettiques/effets des médicaments et des substances chimiques , Tomographie par émission de positons , Graisse sous-cutanée/imagerie diagnostique , Graisse sous-cutanée/effets des médicaments et des substances chimiques , Sus scrofa , Facteurs temps
8.
Med. interna Méx ; 33(5): 682-689, sep.-oct. 2017. tab, graf
Article de Espagnol | LILACS | ID: biblio-894310

RÉSUMÉ

Resumen Gran parte de los pacientes con mieloma múltiple inician con signos y síntomas relacionados con la infiltración de células plasmáticas o el exceso de cadenas ligeras kappa. La enfermedad renal es común con enfermedad heterogénea que puede involucrar diferentes mecanismos. Se comunica el caso de un paciente con sospecha de mieloma múltiple debido a la existencia de lumbalgia, insuficiencia renal, anemia e hipercalcemia; con electroforesis de proteínas séricas negativa para hipergammaglobulinemia, en quien se confirmó el diagnóstico al demostrar la existencia de cadenas ligeras kappa en tejido renal; se realiza una revisión de la bibliografía actual.


Abstract Much of the patients with multiple myeloma present with signs and symptoms related to plasma cells infiltration or by the excess of kappa light chains. Kidney disease is common and has a heterogeneous pathophysiology that may involve different mechanisms. We present the case of a patient with suspected multiple myeloma because of low back pain, renal failure, anemia and hypercalcemia; without hipergammaglobulinemia in the electrophoresis, in whom the diagnosis was confirmed by the presence of kappa chains light in renal tissue; a review of current literature is made.

9.
AJNR Am J Neuroradiol ; 38(10): 1905-1910, 2017 Oct.
Article de Anglais | MEDLINE | ID: mdl-28838913

RÉSUMÉ

BACKGROUND AND PURPOSE: Limited information is available regarding differences in neuroimaging use for acute stroke work-up. Our objective was to assess whether race, sex, or age differences exist in neuroimaging use and whether these differences depend on the care center type in a population-based study. MATERIALS AND METHODS: Patients with stroke (ischemic and hemorrhagic) and transient ischemic attack were identified in a metropolitan, biracial population using the Greater Cincinnati/Northern Kentucky Stroke Study in 2005 and 2010. Multivariable regression was used to determine the odds of advanced imaging use (CT angiography/MR imaging/MR angiography) for race, sex, and age. RESULTS: In 2005 and 2010, there were 3471 and 3431 stroke/TIA events, respectively. If one adjusted for covariates, the odds of advanced imaging were higher for younger (55 years or younger) compared with older patients, blacks compared with whites, and patients presenting to an academic center and those seen by a stroke team or neurologist. The observed association between race and advanced imaging depended on age; in the older age group, blacks had higher odds of advanced imaging compared with whites (odds ratio, 1.34; 95% CI, 1.12-1.61; P < .01), and in the younger group, the association between race and advanced imaging was not statistically significant. Age by race interaction persisted in the academic center subgroup (P < .01), but not in the nonacademic center subgroup (P = .58). No significant association was found between sex and advanced imaging. CONCLUSIONS: Within a large, biracial stroke/TIA population, there is variation in the use of advanced neuroimaging by age and race, depending on the care center type.


Sujet(s)
Disparités d'accès aux soins/statistiques et données numériques , Neuroimagerie/statistiques et données numériques , Accident vasculaire cérébral/imagerie diagnostique , Sujet âgé , Sujet âgé de 80 ans ou plus , , Femelle , Humains , Accident ischémique transitoire/imagerie diagnostique , Accident ischémique transitoire/épidémiologie , Mâle , Adulte d'âge moyen , Odds ratio , Accident vasculaire cérébral/épidémiologie ,
11.
Hum Vaccin Immunother ; 12(9): 2419-21, 2016 Sep.
Article de Anglais | MEDLINE | ID: mdl-27070956

RÉSUMÉ

The intussusception is one of the most frequent causes of occlusive syndrome in infants and in children. (1) The mesenteric lymphadenopathy, wich is very rare post rotavirus vaccination, can cause intussusception, (2-5) especially in genetically predisposed individuals. (6) There is an association between intussusception and some classes of genotype. (7-9) Two infants aged 3 months, vaccinated against rotavirus. After about a week, one of the 2 identical infants presented inconsolable crying, vomiting, loose stools mixed with blood, and was diagnosed with bowel obstruction with intussusception. He was operated in urgency. After a few hours, his brother presented vomiting, and was admitted to our Hospital for suspected intussusception. The controls carried out have confirmed the presence of intussusception that was treated early, before the onset of severe symptoms. The incidence of post rotavirus vaccine intussusception is very low. The determining factor hypothetically might be linked to the presence of a genotype that exposes infants to a greater risk of developing mesenteric lymphadenitis and intussusception. In our case, the diagnosis of intussusception occurred in a twin, which allowed us to recognize early symptoms which accused the brother and schedule the surgery with less urgency. Our experience may want to sensitize families and pediatricians to report cases of intussusception given a theoretical familiar association. The study of the genotype could be decisive for or not to exclude the presence of a risk of invagination, thus avoiding vaccination.


Sujet(s)
Intussusception/induit chimiquement , Intussusception/anatomopathologie , Vaccins anti-rotavirus/administration et posologie , Vaccins anti-rotavirus/effets indésirables , Humains , Nourrisson , Intussusception/chirurgie , Mâle , Jumeaux monozygotes
12.
Eur J Surg Oncol ; 42(2): 260-5, 2016 Feb.
Article de Anglais | MEDLINE | ID: mdl-26723169

RÉSUMÉ

AIM: The number of examined lymph nodes (NLN) was associated with survival of stages II and III colorectal cancer (CRC) patients. Guidelines recommend examining at least 12 lymph nodes. This study investigated the influence of surgical specimen length on lymph node harvest and compliance with international guidelines. MATERIALS AND METHODS: This population-based study included 4,724 cases of surgically treated CRC that were diagnosed from 2002 to 2008. Multivariate analyses were performed for the main study variables (age, gender, diagnosis at screening or in symptomatic patients, cancer site, staging, grading, number of positive nodes, neo-adjuvant treatment for rectal cancer, hospital were surgery was performed). Fractional polynomial models investigated the relationship between continuous variables and outcomes. RESULTS: The NLN increased over time reaching ≥12 NLN in 64% of cases at the end of the study period. More NLN were associated with young age, right colon cancer, pT3-T4 disease, stages II and III and high grade. Fewer NLN were associated with short surgical specimen length and neo-adjuvant treatment in rectal cancer patients. Use of laparoscopy increased sharply over time. CONCLUSIONS: NLN increased over time in accordance with international guidelines. Surgical specimen length correlated with NLN which may determine therapeutic choices, particularly in stage II colon cancer. When harvested lymph nodes are under 10 in number and all are negative, chemotherapy is always recommended. As specimen lengths <20 cm were associated with a high risk of inadequate NLN counts, patients are at risk of over-treatment.


Sujet(s)
Tumeurs du côlon/anatomopathologie , Noeuds lymphatiques/anatomopathologie , Tumeurs du rectum/anatomopathologie , Facteurs âges , Sujet âgé , Sujet âgé de 80 ans ou plus , Côlon ascendant , Tumeurs du côlon/chirurgie , Femelle , Humains , Lymphadénectomie , Noeuds lymphatiques/chirurgie , Métastase lymphatique , Mâle , Adulte d'âge moyen , Grading des tumeurs , Stadification tumorale , Guides de bonnes pratiques cliniques comme sujet , Tumeurs du rectum/chirurgie , Facteurs sexuels
13.
Rev Clin Esp (Barc) ; 216(5): 288, 2016.
Article de Anglais, Espagnol | MEDLINE | ID: mdl-26708226
14.
Actas urol. esp ; 39(7): 456-459, sept. 2015. tab
Article de Espagnol | IBECS | ID: ibc-143735

RÉSUMÉ

Introducción: La terapia de ondas de choque lineales (LSWT) es una nueva terapia no invasiva que utiliza ondas de choque de baja intensidad para inducir la angiogénesis local controlada y mejorar significativamente la función eréctil. Objetivo: Evaluar la eficacia de la LSWT en hombres con disfunción eréctil vasculogénica (DE) en un centro de atención de tercer nivel. Material y métodos: Se incluyeron 15 hombres de edades comprendidas entre 45 y 70 años, sexualmente activos con DE vascular leve y moderada, evaluados con el índice internacional de función eréctil (IIEF). El estudio se realizó en 3 etapas: detección, tratamiento y seguimiento. Recibieron 4 sesiones de LSWT semanales (RENOVA®) 5.000 ondas (0,09 mJ/mm2). La función eréctil se evaluó con IIEFF-EF, Perfil del encuentro sexual (SEP) y Cuestionario de evaluación global (GAQ) al mes y a los 6 meses después del tratamiento. Resultados: La tasa de éxito fue del 80% (12/15). Pacientes con DE leve 40% y DE moderada 60%. Se encontró una asociación positiva entre el IIEF-basal (promedio 14,23 pts) y IIEF un mes y 6 meses después del tratamiento (19,69 pts) una diferencia de 5,46 puntos (p < 0,013). Conclusiones: La factibilidad y tolerabilidad de este tratamiento, y sus características potenciales de rehabilitación, hacen que pueda ser una nueva opción terapéutica atractiva para pacientes con DE


Introduction: Linear Shock Wave Therapy (LSWT) is a new noninvasive therapy that uses low-intensity shock waves to induce local angiogenesis promising modality in the treatment of erectile dysfunction (ED). Objective: To evaluate the effectiveness of LSWT in men with vasculogenic erectile dysfunction (ED), in a Tertiary Care Center. Material and methods: Included 15 men aged 45-70 years, sexually active with mild and moderate vascular ED evaluated with the International Index of Erectile Function (IIEF). The study was conducted in three stage: screening, treatment and results. Treatment stage: 4 weekly sessions LSWT (RENOVA ®) 5000 waves (.09 mJ/mm2). Erectile function was assessed with IIEFF-EF, SEP (Sexual Encounter Profile) and GAQ (Global Assessment Questions) at one and six months after treatment. Results: The rate of success was 80% (12/15). Patients with mild ED (6/15) 40% and moderate ED (9/15) 60%. We found a positive association between IIEF-Basal (average 14.23 pts) and IIEF at one month and six months after therapy (19.69 pts) a difference of 5.46 pts. (P < .013). Conclusions: The feasibility and tolerability of this treatment, and rehabilitation potential features, make it this an attractive new treatment option for patients with ED


Sujet(s)
Sujet âgé , Humains , Mâle , Dysfonctionnement érectile/thérapie , Impuissance vasculaire/thérapie , Agents angiogéniques/usage thérapeutique , Thérapie à ondes courtes
15.
Arch Soc Esp Oftalmol ; 90(12): 562-5, 2015 Dec.
Article de Anglais, Espagnol | MEDLINE | ID: mdl-26279484

RÉSUMÉ

OBJECTIVE: To determine the importance of intratumoral genetic analysis in the diagnosis of germ-line mutations in patients with retinoblastoma. To underline the importance of performing these genetic tests in every case of retinoblastoma. METHOD: Intratumoral genetic analysis of RB1 mutation was performed on 17 enucleated eyes that were non-responsive to conservative treatment. Patients had no family history of retinoblastoma, and lesions were always single. The identified mutations were then also studied in peripheral blood analysis. RESULTS: There were 12 (70.6%) cases with positive results in intratumoral analysis. In 8 cases (47.1%) mutation of both RB1 alelli were detected, and in 4 (23.5%) cases only one allele was found mutated. In 5 patients (29.4%) no mutation was identified. In the first hit, mutations comprised 7 frameshift or nonsense and 2 splice, whereas in the second hit, one splice mutation, 2 nonsense and 8 loss of heterozygosity were identified. Among 6 patients where intratumoral analysis detected a single mutation associated with a loss of heterozygosity, the peripheral blood analysis was able to detect the same mutation in 3 cases (50%). CONCLUSIONS: Intratumoral genetic analysis of sporadic retinoblastoma can detect germ-line mutations. These patients are at higher risk of bilateralization and development of second tumors or trilateral retinoblastoma. Genetic screening is recommended in every patient diagnosed with retinoblastoma.


Sujet(s)
Tumeurs de l'oeil/génétique , Mutation , Rétinoblastome/génétique , Allèles , Analyse de mutations d'ADN , Énucléation oculaire , Tumeurs de l'oeil/sang , Tumeurs de l'oeil/composition chimique , Tumeurs de l'oeil/chirurgie , Gènes du rétinoblastome , Dépistage génétique , Mutation germinale , Humains , Perte d'hétérozygotie , Protéines tumorales/sang , Protéines tumorales/génétique , Spécificité d'organe , Rétinoblastome/sang , Rétinoblastome/composition chimique , Rétinoblastome/chirurgie , Protéines de liaison à la protéine du rétinoblastome/analyse , Protéines de liaison à la protéine du rétinoblastome/sang , Protéines de liaison à la protéine du rétinoblastome/génétique , Protéine du rétinoblastome/sang , Protéine du rétinoblastome/génétique , Ubiquitin-protein ligases/analyse , Ubiquitin-protein ligases/sang , Ubiquitin-protein ligases/génétique
16.
Article de Anglais | MEDLINE | ID: mdl-26262244

RÉSUMÉ

Determining the priority of attention in an Emergency Room (ER) has always been a difficult issue. Priority is determined with a simple triage system as people arrive at the hospital. It is important to establish how long they can wait for treatment. In order to obtain the best assessment of patients' conditions, we built a Nursing Software for Emergency Triage (NSET). The objective of this work was to assess the efficacy of the NSET versus the triage process without any software (TWS). Results showed that the NSET we built was a substantial help. With this software, we decreased significantly:1) the length of the triage system process, 2) the waiting time of patients in the waiting room, 3) the number of complaints and 4) the number of patients who walk away. In conclusion, the NSET improves and helps to define more accurately a patient's risk. NSET helps in the emergency department triage.


Sujet(s)
Systèmes d'aide à la décision clinique , Soins infirmiers aux urgences/méthodes , Logiciel , Triage/méthodes , Soins infirmiers aux urgences/statistiques et données numériques , Service hospitalier d'urgences/statistiques et données numériques , Humains
17.
Actas Urol Esp ; 39(7): 456-9, 2015 Sep.
Article de Anglais, Espagnol | MEDLINE | ID: mdl-25724753

RÉSUMÉ

INTRODUCTION: Linear Shock Wave Therapy (LSWT) is a new noninvasive therapy that uses low-intensity shock waves to induce local angiogenesis promising modality in the treatment of erectile dysfunction (ED). OBJECTIVE: To evaluate the effectiveness of LSWT in men with vasculogenic erectile dysfunction (ED), in a Tertiary Care Center. MATERIAL AND METHODS: Included 15 men aged 45-70 years, sexually active with mild and moderate vascular ED evaluated with the International Index of Erectile Function (IIEF). The study was conducted in three stage: screening, treatment and results. Treatment stage: 4 weekly sessions LSWT (RENOVA ®) 5000 waves (.09mJ/mm(2)). Erectile function was assessed with IIEFF-EF, SEP (Sexual Encounter Profile) and GAQ (Global Assessment Questions) at one and six months after treatment. RESULTS: The rate of success was 80% (12/15). Patients with mild ED (6/15) 40% and moderate ED (9/15) 60%. We found a positive association between IIEF-Basal (average 14.23 pts) and IIEF at one month and six months after therapy (19.69 pts) a difference of 5.46 pts. (P<.013). CONCLUSIONS: The feasibility and tolerability of this treatment, and rehabilitation potential features, make it this an attractive new treatment option for patients with ED.


Sujet(s)
Impuissance vasculaire/thérapie , Ultrasonothérapie , Sujet âgé , Humains , Mâle , Adulte d'âge moyen
18.
Arch Soc Esp Oftalmol ; 90(9): 414-20, 2015 Sep.
Article de Espagnol | MEDLINE | ID: mdl-25817468

RÉSUMÉ

OBJECTIVE: To analyze the genetic alterations identified in the RB1 gene in retinoblastoma patients who do not respond to systemic chemotherapy. METHODS: A genetic analysis was performed on 115 patients with retinoblastoma, 40 of whom had received systemic chemotherapy, and 29 of them had bilateral disease. Descriptive and retrospective study. Non-responders were considered as patients who are finally enucleated. RESULTS: Patients with deletion type mutations are those with less preservation of the eyeball (Pearson Chi-square, P=.055). Patients with an impaired nonsense-frameshift type are more likely to preserve the eyeball. Of the 3 patients who had undergone bilateral enucleation, 2 of them had deletions and one missense alteration. Survival analysis (Kaplan-Meier curve) shows that patients with deletion type mutations are more resistance to chemotherapy, are suffering higher rates of enucleation, and for a shorter period of time (log rank [Mantel-Cox] with a significance level of P=.053), which are also associated with increased rate of being bilateral. CONCLUSIONS: Patients with a genotype show increased resistance to chemotherapy should be evaluated more closely and treated with various therapeutic weapons early. Patients that have deletions in the RB1 gene are at increased risk of chemoresistance. It is likely that other genetic alterations other than RB1 gene may be related to tumor aggressiveness and treatment resistance.


Sujet(s)
Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Mutation , Tumeurs de la rétine/génétique , Protéines de liaison à la protéine du rétinoblastome/génétique , Rétinoblastome/génétique , Ubiquitin-protein ligases/génétique , Analyse de mutations d'ADN , Résistance aux médicaments antinéoplasiques , Énucléation oculaire , Femelle , Génotype , Humains , Estimation de Kaplan-Meier , Mâle , Invasion tumorale , Tumeurs primitives multiples/traitement médicamenteux , Tumeurs primitives multiples/génétique , Tumeurs primitives multiples/chirurgie , Modèles des risques proportionnels , Tumeurs de la rétine/traitement médicamenteux , Tumeurs de la rétine/chirurgie , Rétinoblastome/traitement médicamenteux , Rétinoblastome/chirurgie , Études rétrospectives , Délétion de séquence
19.
Br J Cancer ; 111(9): 1810-3, 2014 Oct 28.
Article de Anglais | MEDLINE | ID: mdl-25290092

RÉSUMÉ

BACKGROUND: Month of birth influences the risk of developing several diseases. We investigated the influence of date of birth on melanoma skin cancer (MSC) and non-melanoma skin cancer (NMSC) incidence. METHODS: Enhanced cancer registry data were analysed including 1751 MSC and 15 200 NMSC. RESULTS: People born in February to April showed significantly elevated risks of NMSC compared with those born in summertime. CONCLUSIONS: We demonstrated seasonality by date of birth for skin cancer incidence. Neonatal UV exposure may explain this finding.


Sujet(s)
Carcinome basocellulaire/épidémiologie , Carcinome épidermoïde/épidémiologie , Mélanome/épidémiologie , Parturition , Saisons , Tumeurs cutanées/épidémiologie , Femelle , Études de suivi , Humains , Incidence , Italie/épidémiologie , Mâle , Stadification tumorale , Pronostic , Facteurs de risque ,
20.
Nutrition ; 30(2): 177-85, 2014 Feb.
Article de Anglais | MEDLINE | ID: mdl-24377452

RÉSUMÉ

OBJECTIVE: Insulin resistance (IR) and white adipose tissue (WAT) dysfunction frequently are associated with nonalcoholic fatty liver disease (NAFLD); however, the pathogenic mechanisms contributing to their clustering are not well defined. The aim of this study was to define some nutritional, anthropometric, metabolic, and genetic mechanisms contributing to their clustering. METHODS: Forty-five (20 men, 25 women) patients (age 45.7 ± 11.1 y) with recent diagnosis of NAFLD were grouped according to IR state. Energy balance was assessed using a food questionnaire and indirect calorimetry, and body composition with anthropometry and dual-energy x-ray absorptiometry. Biochemical and hormonal parameters combined with adipose tissue gene expression were determined. Microarray analysis of gene expression was performed in a subset of WAT samples from IR patients (n = 9), in the fasted state, after specific test meals (monounsaturated fatty acid [MUFA], saturated fat [SAT], and carbohydrate-rich) and after being challenged with insulin. RESULTS: IR patients exhibited higher trunk fat to leg fat ratio (P < 0.05) and had a higher ratio of SAT/MUFA fat intake (P < 0.05) than insulin-sensitive (IS) individuals. Deposition of fat in the trunk but not in the leg was directly related to liver enzyme levels (P < 0.05). IR patients also had lower adiponectin serum levels and leptin (LEP) mRNA expression in WAT compared with IS patients (P < 0.01 and P < 0.05, respectively). Microarray analysis after insulin challenge confirmed that insulin treatment induces the expression of PPARG gene and LEP and decreases GCGR gene (P < 0.05 for all) in WAT. No changes in these genes were observed in the postprandial state induced after the acute effect of specific diets. CONCLUSIONS: Patients exhibiting NAFLD and IR had preferential central fat deposition directly related to their serum alanine aminotransferase levels. These patients showed peripheral adipose tissue dysfunction and exhibited inappropriately low LEP biosynthesis that could be partially restored after anabolic conditions induced by insulin signaling.


Sujet(s)
Tissu adipeux blanc/métabolisme , Stéatose hépatique/génétique , Comportement alimentaire , Expression des gènes , Insulinorésistance/génétique , Obésité abdominale/génétique , Absorptiométrie photonique , Adiponectine/sang , Adulte , Composition corporelle , Indice de masse corporelle , Études croisées , Hydrates de carbone alimentaires/administration et posologie , Métabolisme énergétique , Acides gras/administration et posologie , Acides gras monoinsaturés/administration et posologie , Stéatose hépatique/diétothérapie , Femelle , Humains , Insuline/sang , Interleukine-6/sang , Leptine/sang , Mâle , Adulte d'âge moyen , Stéatose hépatique non alcoolique , État nutritionnel , ARN messager/génétique , ARN messager/métabolisme , Essais contrôlés randomisés comme sujet , Enquêtes et questionnaires , Facteur de nécrose tumorale alpha/sang
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE